![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Week 96 Renal Safety Update of
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF
from Two Phase 3 Randomized Controlled Trials
|
|
|
Reported by Jules Levin
14th European AIDS Conference
16-19 October, 2013
Brussels, Belgium
F Post1, J Winston2, B Hendry1, B Gazzard3, J Molina4,
HC Liu5, D Piontkowsky5, AK Cheng5, MS Rhee5, J Szwarcberg5
1King's College London School of Medicine, London, UK; 2Mount Sinai School of Medicine, New York, US;
3Chelsea and Westminster Hospital, London, UK; 4Saint-Louis Hospital and University of Paris Diderot, Paris, France; 5Gilead Sciences, Foster City, US
![EACS1.gif](../images/101813/101813-3/EACS1.gif)
![EACS2.gif](../images/101813/101813-3/EACS2.gif)
![EACS3.gif](../images/101813/101813-3/EACS3.gif)
![EACS4.gif](../images/101813/101813-3/EACS4.gif)
![EACS5.gif](../images/101813/101813-3/EACS5.gif)
![EACS6.gif](../images/101813/101813-3/EACS6.gif)
![EACS7.gif](../images/101813/101813-3/EACS7.gif)
![EACS8.gif](../images/101813/101813-3/EACS8.gif)
![EACS9.gif](../images/101813/101813-3/EACS9.gif)
![EACS10.gif](../images/101813/101813-3/EACS10.gif)
![EACS11.gif](../images/101813/101813-3/EACS11.gif)
![EACS12.gif](../images/101813/101813-3/EACS12.gif)
![EACS13.gif](../images/101813/101813-3/EACS13.gif)
![EACS14.gif](../images/101813/101813-3/EACS14.gif)
![EACS15.gif](../images/101813/101813-3/EACS15.gif)
![EACS16.gif](../images/101813/101813-3/EACS16.gif)
![EACS17.gif](../images/101813/101813-3/EACS17.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|